1. Home
  2. HRL vs AXSM Comparison

HRL vs AXSM Comparison

Compare HRL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

HOLD

Current Price

$24.75

Market Cap

11.8B

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$255.17

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRL
AXSM
Founded
1891
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
12.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
HRL
AXSM
Price
$24.75
$255.17
Analyst Decision
Buy
Strong Buy
Analyst Count
6
17
Target Price
$26.50
$211.12
AVG Volume (30 Days)
4.9M
583.5K
Earning Date
05-28-2026
05-04-2026
Dividend Yield
5.61%
N/A
EPS Growth
N/A
38.56
EPS
0.62
N/A
Revenue
$12,106,160,000.00
N/A
Revenue This Year
$2.66
$57.24
Revenue Next Year
$1.62
$55.88
P/E Ratio
$39.44
N/A
Revenue Growth
1.55
N/A
52 Week Low
$19.72
$96.09
52 Week High
$31.11
$257.44

Technical Indicators

Market Signals
Indicator
HRL
AXSM
Relative Strength Index (RSI) 76.51 76.03
Support Level $24.15 $148.87
Resistance Level $24.92 N/A
Average True Range (ATR) 0.58 8.40
MACD 0.23 1.04
Stochastic Oscillator 97.88 98.89

Price Performance

Historical Comparison
HRL
AXSM

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: